﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2025v4.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2026-05-14T18:27:34-04:00</ReturnTs>
    <TaxPeriodEndDt>2025-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>461041593</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>FINANCIAL SOLUTION ADVISORS LLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>4350 PABLO PROFESSIONAL COURT</AddressLine1Txt>
        <CityNm>JACKSONVILLE</CityNm>
        <StateAbbreviationCd>FL</StateAbbreviationCd>
        <ZIPCd>32224</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2025-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>341710663</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>CLEVELAND VA MEDICAL RESEARCH AND</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>EDUCATION FOUNDATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>CLEV</BusinessNameControlTxt>
      <PhoneNum>2162313241</PhoneNum>
      <USAddress>
        <AddressLine1Txt>10701 EAST BOULEVARD</AddressLine1Txt>
        <CityNm>CLEVELAND</CityNm>
        <StateAbbreviationCd>OH</StateAbbreviationCd>
        <ZIPCd>44106</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>YNGVE FALCK-YTTER MD</PersonNm>
      <PersonTitleTxt>TREASURER</PersonTitleTxt>
      <PhoneNum>2167912300</PhoneNum>
      <SignatureDt>2026-04-22</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>MICHAEL B MCLEOD CPA</PreparerPersonNm>
      <PTIN>P00966646</PTIN>
      <PhoneNum>9042962024</PhoneNum>
      <PreparationDt>2026-05-14</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2025</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="5">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc4">
      <PrincipalOfficerNm>JEFF MOORE PHD</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>10701 EAST BLVD</AddressLine1Txt>
        <CityNm>CLEVELAND</CityNm>
        <StateAbbreviationCd>OH</StateAbbreviationCd>
        <ZIPCd>44106</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>5207373</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>N/A</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1991</FormationYr>
      <LegalDomicileStateCd>OH</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL RESEARCH AT THE LOUIS STOKES CLEVELAND VA MEDICAL CENTER.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>7</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>2</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>45</TotalEmployeeCnt>
      <TotalVolunteersCnt>9</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>33974</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>19030</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>5392479</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>5148887</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>51130</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>36762</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>2694</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>5477583</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>5207373</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>3235426</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>3018128</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>2475763</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>2538192</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>5711189</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>5556320</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-233606</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-348947</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>4339916</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>3354578</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>1338603</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>701729</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>3001313</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>2652849</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL AND CLINICAL RESEARCH AS WELL AS TO PROVIDE HEALTH-RELATED EDUCATIONAL ACTIVITIES IN CONJUNCTION WITH THE LOUIS STOKES CLEVELAND DEPARTMENT OF VA MEDICAL CENTER (VAMC). RESEARCH SPONSORED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION BENEFITS VETERANS TREATED AT THE LOUIS STOCKS CLEVELAND VAMC AND THE GENERAL PUBLIC BY ADVANCING KNOWLEDGE IN THE DIAGNOSIS AND TREATMENT OF DISEASE AND DISABILITY. EDUCATION PROGRAMS SUPPORTED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION HELP DISSEMINATE THE RESULTS OF RESEARCH SO THEY MAY BE TRANSLATED TO CLINICAL PRACTICE, PROVIDE HOSPITAL STAFF WITH TRAINING IN THE LATEST TREATMENTS, AND HELP PATIENTS UNDERSTAND AND MANAGE THEIR MEDICAL CONDITIONS.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>4581675</ExpenseAmt>
      <Desc>DR. HAMID CHARKHKAR, PHD- DOD "NEURALLY INTEGRATED LOWER LIMB PROSTHESIS FOR HOME AND COMMUNITY USE" THE OBJECTIVE OF THIS STUDY IS TO DEVELOP AND DEPLOY A FULLY IMPLANTABLE, SELF-CONTAINED LOWER LIMB SENSORY NEUROPROSTHESIS THAT IS EASY-TO-USE IN THE COMMUNITY AND/OR ACTIVE-DUTY ENVIRONMENTS. DOING SO COULD PROVIDE WARFIGHTERS WITH LOWER LIMB LOSS THE ABILITY TO POTENTIALLY RETURN TO ACTIVE DUTY OR FACILITATE RESUMPTION OF A HEALTHY AND SOCIALLY ENGAGED LIFESTYLE. CONVENTIONAL PROSTHESES ARE NOT DESIGNED TO EFFECTIVELY INTERFACE WITH COMPROMISED SKELETAL, MUSCULAR, AND NERVOUS SYSTEMS FOLLOWING A LOWER LIMB AMPUTATION. ALTHOUGH NUMEROUS ADVANCED PROSTHESES HAVE BEEN DEVELOPED, NO COMMERCIALLY AVAILABLE DEVICE CAN PROVIDE A DIRECT NEURAL CONNECTION TO THE REMAINING NERVES IN THE RESIDUAL LIMB SO THAT SOMATOSENSORY FEEDBACK OF PROSTHETIC FOOT-FLOOR INTERACTIONS CAN BE UTILIZED. SENSORY RESTORATION APPROACHES USING A DIRECT NEURAL INTERFACE HAVE REPORTED POSITIVE EFFECTS, INCLUDING AN INCREASE IN WALKING SPEED, REDUCTION IN PHANTOM PAIN, AND LIGHTER WEIGHT PERCEPTION OF THE PROSTHESIS. HOWEVER, MOST TESTS WITH THESE SYSTEMS HAVE BEEN PERFORMED IN CONTROLLED LABORATORY ENVIRONMENTS, AND THEIR EFFECTS DURING ACTIVITIES OF DAILY LIVING ARE LARGELY UNKNOWN. PROBING SUCH EFFECTS REQUIRES EXAMINING THE LONG-TERM USE OF THESE PROSTHESES OUTSIDE THE LABORATORY WHILE USERS ENGAGE IN CHALLENGING PHYSICAL ACTIVITIES TYPICAL IN THEIR EVERYDAY LIVES. WE HYPOTHESIZE THAT PROLONGED USE OF THE NEUROPROSTHESIS AT HOME AND IN THE COMMUNITY WILL IMPROVE STANDARD STATIC AND DYNAMIC MEASURES OF BALANCE AND GAIT STABILITY REVEALED THROUGH QUANTITATIVE POSTUROGRAPHY AND GAIT ANALYSIS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <Desc>DR. RONALD TRIOLO, PHD-CRAIG H. NEILSEN FOUNDATION "THE NORTHEAST OHIO PARAROWING SOCIETY" GOAL OF THIS PROJECT IS TO ESTABLISH A NEW PARAROWING PROGRAM FOR INDIVIDUALS WITH SCI IN NORTHEASTERN OHIO. PARAROWING PROGRAMS EXIST IN MANY PARTS OF THE US, BUT SUCH OPPORTUNITIES ARE UNAVAILABLE IN CLEVELAND OR ANYWHERE NORTH OF COLUMBUS FROM TOLEDO TO YOUNGSTOWN. THIS REPRESENTS A SIGNIFICANT BARRIER FOR INDIVIDUALS WITH SCI TO EXPERIENCE THE EXERCISE AND CAMARADERIE OF A DYNAMIC AND EXPANDING REGIONAL ROWING COMMUNITY, AND AN OBSTACLE TO ACCESSING OUR NATURAL RESOURCES AND ENJOYING OPPORTUNITIES FOR SOCIAL ENGAGEMENT. THE NORTHEAST OHIO PARAROWING SOCIETY (NEOPS) WILL REMOVE THESE IMPEDIMENTS TO PARTICIPATION IN THE LOCAL ROWING COMMUNITY AND CREATE A NEW OUTLET TO ACTIVELY TAKE ADVANTAGE OF AN OTHERWISE UNAVAILABLE OPPORTUNITY. OUR OBJECTIVES ARE TO 1) ESTABLISH THE PROCEDURES NECESSARY TO INTRODUCE INDIVIDUALS WITH SCI TO SCULLING IN ADAPTED SHELLS WITH PROPER TECHNIQUE, SPECIALIZED COACHING, AND ADEQUATE SAFETY PRECAUTIONS, 2) BROADEN THE DEMONSTRATION PROJECT INTO A LARGER AND SELF-SUSTAINING CLUB FOR THE LOCAL SCI COMMUNITY, AND 3) EXTEND ROWING PERFORMANCE AND EXERCISE INTENSITY BY TRANSLATING LABORATORY-BASED NEURAL STIMULATION TECHNIQUES TO ON-WATER SCULLING (E-SCULLING)</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <Desc>DR. PERI DAVITKOV, MD-NCI "FORTE (FIVE- OR TEN-YEAR COLONOSCOPY FOR 1-2 NON-ADVANCED ADENOMATOUS POLYPS)" THIS STUDY WILL HELP TO DETERMINE IF CERTAIN PEOPLE CAN WAIT FOR A FOLLOW- UP COLONOSCOPY AFTER A ROUTINE SCREENING COLONOSCOPY. IT IS A RANDOMIZED CLINICAL TRIAL FOR PEOPLE WHO HAVE ONE OR TWO SMALL, NONCANCEROUS POLYPS (ADENOMAS) REMOVED DURING A ROUTINE SCREENING COLONOSCOPY. SUCH PEOPLE USUALLY GET REPEAT COLONOSCOPIES 5 YEARS AND 10 YEARS LATER (THE CURRENT STANDARD OF CARE FOR PEOPLE WHO HAVE HAD ONE OR TWO BENIGN POLYPS REMOVED). FORTE WILL HELP DETERMINE IF THESE PEOPLE CAN WAIT 10 YEARS BEFORE A FOLLOW-UP TEST. A TOTAL OF 9,500 PEOPLE, AT ALL SITES, WHO HAVE HAD ONE OR TWO BENIGN (NONCANCEROUS) POLYPS REMOVED DURING A ROUTINE SCREENING COLONOSCOPY WILL BE ASSIGNED BY CHANCE TO ONE OF TWO STUDY GROUPS. IN ONE GROUP, PARTICIPANTS WILL HAVE REPEAT COLONOSCOPIES AT BOTH 5 AND 10 YEARS. IN THE OTHER GROUP, PARTICIPANTS WILL HAVE THEIR NEXT COLONOSCOPY EXAM AT 10 YEARS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <Desc>OTHER RESEARCH AND SERVICE ACTIVITIES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalProgramServiceExpensesAmt>4581675</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc5">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc2">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc2">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc2">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc2">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc2">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc2">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc2">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc2">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc2">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc2">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc2">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc2">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc2">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc3">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>6</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>45</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>7</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>2</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>JEFF MOORE PHD</PersonNm>
        <PhoneNum>2162313241</PhoneNum>
        <USAddress>
          <AddressLine1Txt>10701 EAST BLVD</AddressLine1Txt>
          <CityNm>CLEVELAND</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>44106</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>JEFF MOORE PHD</PersonNm>
        <TitleTxt>EXECUTIVE DI</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>156434</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>19044</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BRIGID WILSON</PersonNm>
        <TitleTxt>HCE</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>128285</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>40185</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD DECHANT</PersonNm>
        <TitleTxt>TRUSTEE/DIRE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANDREW PACYNA FACHE</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>GEORGE JASKIW MD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MURRAY ALTOSE MD</PersonNm>
        <TitleTxt>TRUSTEE/DIRE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SIMRAN SINGH MD</PersonNm>
        <TitleTxt>TRUSTEE/DIRE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>YNGVE FALCK-YTTER MD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NEAL PEACHEY PHD</PersonNm>
        <TitleTxt>VICE PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>284719</TotalReportableCompFromOrgAmt>
      <TotalOtherCompensationAmt>59229</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>2</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>19030</AllOtherContributionsAmt>
      <TotalContributionsAmt>19030</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>FEDERAL CONT &amp; GRANT REV</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>2799417</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2799417</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>NON-FEDERAL CONT &amp; GRANT REV</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>2036833</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2036833</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>IPA REVENUE</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>312637</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>312637</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>5148887</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>36762</TotalRevenueColumnAmt>
        <ExclusionAmt>36762</ExclusionAmt>
      </InvestmentIncomeGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>2694</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>2694</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>2694</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>5207373</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5151581</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>36762</ExclusionAmt>
      </TotalRevenueGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>2412063</TotalAmt>
        <ProgramServicesAmt>1711049</ProgramServicesAmt>
        <ManagementAndGeneralAmt>701014</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>87102</TotalAmt>
        <ProgramServicesAmt>61454</ProgramServicesAmt>
        <ManagementAndGeneralAmt>25648</ManagementAndGeneralAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>333146</TotalAmt>
        <ProgramServicesAmt>275711</ProgramServicesAmt>
        <ManagementAndGeneralAmt>57435</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>185817</TotalAmt>
        <ProgramServicesAmt>128324</ProgramServicesAmt>
        <ManagementAndGeneralAmt>57493</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>21695</TotalAmt>
        <ManagementAndGeneralAmt>21695</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>41752</TotalAmt>
        <ProgramServicesAmt>30414</ProgramServicesAmt>
        <ManagementAndGeneralAmt>11338</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>9669</TotalAmt>
        <ProgramServicesAmt>1784</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7885</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>25185</TotalAmt>
        <ProgramServicesAmt>5317</ProgramServicesAmt>
        <ManagementAndGeneralAmt>19868</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>69116</TotalAmt>
        <ProgramServicesAmt>59334</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9782</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>75605</TotalAmt>
        <ProgramServicesAmt>59010</ProgramServicesAmt>
        <ManagementAndGeneralAmt>16595</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <InsuranceGrp>
        <TotalAmt>6763</TotalAmt>
        <ManagementAndGeneralAmt>6763</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>RESEARCH SUPPORT COSTS</Desc>
        <TotalAmt>2090664</TotalAmt>
        <ProgramServicesAmt>2053374</ProgramServicesAmt>
        <ManagementAndGeneralAmt>37290</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PARTICIPANT COMPENSATION</Desc>
        <TotalAmt>66489</TotalAmt>
        <ProgramServicesAmt>66489</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>PROVISION FOR CREDIT LOSS</Desc>
        <TotalAmt>50742</TotalAmt>
        <ProgramServicesAmt>50742</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>RESEARCH SUBWARDS</Desc>
        <TotalAmt>35058</TotalAmt>
        <ProgramServicesAmt>35058</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>45454</TotalAmt>
        <ProgramServicesAmt>43615</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1839</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>5556320</TotalAmt>
        <ProgramServicesAmt>4581675</ProgramServicesAmt>
        <ManagementAndGeneralAmt>974645</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>347577</BOYAmt>
        <EOYAmt>481733</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>489090</BOYAmt>
        <EOYAmt>1106573</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>3496918</BOYAmt>
        <EOYAmt>1763685</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>6331</BOYAmt>
        <EOYAmt>2587</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <TotalAssetsGrp>
        <BOYAmt>4339916</BOYAmt>
        <EOYAmt>3354578</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>1315418</BOYAmt>
        <EOYAmt>684482</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>23185</BOYAmt>
        <EOYAmt>17247</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>1338603</BOYAmt>
        <EOYAmt>701729</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>3001313</BOYAmt>
        <EOYAmt>2550526</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <EOYAmt>102323</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>3001313</BOYAmt>
        <EOYAmt>2652849</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>4339916</BOYAmt>
        <EOYAmt>3354578</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-348947</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>483</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>false</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>true</FederalGrantAuditRequiredInd>
      <FederalGrantAuditPerformedInd>true</FederalGrantAuditPerformedInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc5">
      <MedicalResearchOrganizationInd>X</MedicalResearchOrganizationInd>
      <HospitalNameAndAddressGrp>
        <SupportedOrganizationName>
          <BusinessNameLine1Txt>CLEVELAND VA MEDICAL CENTER</BusinessNameLine1Txt>
        </SupportedOrganizationName>
        <CityNm>CLEVELAND</CityNm>
        <StateAbbreviationCd>OH</StateAbbreviationCd>
      </HospitalNameAndAddressGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleD documentId="RetDoc2">
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>5207856</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>483</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>483</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>5207373</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>5207373</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>5556320</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>5556320</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>5556320</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 3, PART X</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION QUALIFIES AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C) (3) OF THE INTERNAL REVENUE CODE (IRC). THE FOUNDATION PERIODICALLY ASSESSES WHETHER IT HAS INCURRED INCOME TAX EXPENSE OR RELATED INTEREST OR PENALTIES IN ACCORDANCE WITH ACCOUNTING FOR UNCERTAIN TAX POSITIONS. NO SUCH AMOUNTS WERE RECOGNIZED FOR THE YEARS ENDING DECEMBER 31, 2025 AND 2024, RESPECTIVELY. SHOULD THE FOUNDATIONS TAX-EXEMPT STATUS BE CHALLENGED IN THE FUTURE, THE FOUNDATIONS 2023, 2024, AND 2025 TAX YEARS ARE OPEN FOR EXAMINATION BY THE IRS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleJ documentId="RetDoc3">
      <Form990OfOtherOrganizationsInd>X</Form990OfOtherOrganizationsInd>
      <CompensationSurveyInd>X</CompensationSurveyInd>
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JEFF MOORE PHD</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <BaseCompensationFilingOrgAmt>151434</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>5000</BonusFilingOrganizationAmount>
        <NontaxableBenefitsFilingOrgAmt>19044</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>175478</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>BRIGID WILSON</PersonNm>
        <TitleTxt>HCE</TitleTxt>
        <BaseCompensationFilingOrgAmt>128285</BaseCompensationFilingOrgAmt>
        <NontaxableBenefitsFilingOrgAmt>40185</NontaxableBenefitsFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>168470</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc4">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>THE PRIMARY TAX-EXEMPT PURPOSE OF THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION, A 501(C)(3) MEDICAL RESEARCH FOUNDATION ESTABLISHED IN ACCORDANCE WITH TITLE 38, SUBCHAPTER IV-RESEARCH AND EDUCATION CORPORATIONS, SECTIONS 7361-7368, IS TO SUPPORT BIOMEDICAL AND CLINICAL RESEARCH AS WELL AS TO PROVIDE HEALTH-RELATED EDUCATIONAL ACTIVITIES IN CONJUNCTION WITH THE LOUIS STOKES CLEVELAND DEPARTMENT OF VA MEDICAL CENTER (VAMC). RESEARCH SPONSORED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION BENEFITS VETERANS TREATED AT THE LOUIS STOCKS CLEVELAND VAMC AND THE GENERAL PUBLIC BY ADVANCING KNOWLEDGE IN THE DIAGNOSIS AND TREATMENT OF DISEASE AND DISABILITY. EDUCATION PROGRAMS SUPPORTED BY THE CLEVELAND VA MEDICAL RESEARCH AND EDUCATION FOUNDATION HELP DISSEMINATE THE RESULTS OF RESEARCH SO THEY MAY BE TRANSLATED TO CLINICAL PRACTICE, PROVIDE HOSPITAL STAFF WITH TRAINING IN THE LATEST TREATMENTS, AND HELP PATIENTS UNDERSTAND AND MANAGE THEIR MEDICAL CONDITIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>DR. HAMID CHARKHKAR, PHD- DOD "NEURALLY INTEGRATED LOWER LIMB PROSTHESIS FOR HOME AND COMMUNITY USE" THE OBJECTIVE OF THIS STUDY IS TO DEVELOP AND DEPLOY A FULLY IMPLANTABLE, SELF-CONTAINED LOWER LIMB SENSORY NEUROPROSTHESIS THAT IS EASY-TO-USE IN THE COMMUNITY AND/OR ACTIVE-DUTY ENVIRONMENTS. DOING SO COULD PROVIDE WARFIGHTERS WITH LOWER LIMB LOSS THE ABILITY TO POTENTIALLY RETURN TO ACTIVE DUTY OR FACILITATE RESUMPTION OF A HEALTHY AND SOCIALLY ENGAGED LIFESTYLE. CONVENTIONAL PROSTHESES ARE NOT DESIGNED TO EFFECTIVELY INTERFACE WITH COMPROMISED SKELETAL, MUSCULAR, AND NERVOUS SYSTEMS FOLLOWING A LOWER LIMB AMPUTATION. ALTHOUGH NUMEROUS ADVANCED PROSTHESES HAVE BEEN DEVELOPED, NO COMMERCIALLY AVAILABLE DEVICE CAN PROVIDE A DIRECT NEURAL CONNECTION TO THE REMAINING NERVES IN THE RESIDUAL LIMB SO THAT SOMATOSENSORY FEEDBACK OF PROSTHETIC FOOT-FLOOR INTERACTIONS CAN BE UTILIZED. SENSORY RESTORATION APPROACHES USING A DIRECT NEURAL INTERFACE HAVE REPORTED POSITIVE EFFECTS, INCLUDING AN INCREASE IN WALKING SPEED, REDUCTION IN PHANTOM PAIN, AND LIGHTER WEIGHT PERCEPTION OF THE PROSTHESIS. HOWEVER, MOST TESTS WITH THESE SYSTEMS HAVE BEEN PERFORMED IN CONTROLLED LABORATORY ENVIRONMENTS, AND THEIR EFFECTS DURING ACTIVITIES OF DAILY LIVING ARE LARGELY UNKNOWN. PROBING SUCH EFFECTS REQUIRES EXAMINING THE LONG-TERM USE OF THESE PROSTHESES OUTSIDE THE LABORATORY WHILE USERS ENGAGE IN CHALLENGING PHYSICAL ACTIVITIES TYPICAL IN THEIR EVERYDAY LIVES. WE HYPOTHESIZE THAT PROLONGED USE OF THE NEUROPROSTHESIS AT HOME AND IN THE COMMUNITY WILL IMPROVE STANDARD STATIC AND DYNAMIC MEASURES OF BALANCE AND GAIT STABILITY REVEALED THROUGH QUANTITATIVE POSTUROGRAPHY AND GAIT ANALYSIS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>DR. RONALD TRIOLO, PHD-CRAIG H. NEILSEN FOUNDATION "THE NORTHEAST OHIO PARAROWING SOCIETY" GOAL OF THIS PROJECT IS TO ESTABLISH A NEW PARAROWING PROGRAM FOR INDIVIDUALS WITH SCI IN NORTHEASTERN OHIO. PARAROWING PROGRAMS EXIST IN MANY PARTS OF THE US, BUT SUCH OPPORTUNITIES ARE UNAVAILABLE IN CLEVELAND OR ANYWHERE NORTH OF COLUMBUS FROM TOLEDO TO YOUNGSTOWN. THIS REPRESENTS A SIGNIFICANT BARRIER FOR INDIVIDUALS WITH SCI TO EXPERIENCE THE EXERCISE AND CAMARADERIE OF A DYNAMIC AND EXPANDING REGIONAL ROWING COMMUNITY, AND AN OBSTACLE TO ACCESSING OUR NATURAL RESOURCES AND ENJOYING OPPORTUNITIES FOR SOCIAL ENGAGEMENT. THE NORTHEAST OHIO PARAROWING SOCIETY (NEOPS) WILL REMOVE THESE IMPEDIMENTS TO PARTICIPATION IN THE LOCAL ROWING COMMUNITY AND CREATE A NEW OUTLET TO ACTIVELY TAKE ADVANTAGE OF AN OTHERWISE UNAVAILABLE OPPORTUNITY. OUR OBJECTIVES ARE TO 1) ESTABLISH THE PROCEDURES NECESSARY TO INTRODUCE INDIVIDUALS WITH SCI TO SCULLING IN ADAPTED SHELLS WITH PROPER TECHNIQUE, SPECIALIZED COACHING, AND ADEQUATE SAFETY PRECAUTIONS, 2) BROADEN THE DEMONSTRATION PROJECT INTO A LARGER AND SELF-SUSTAINING CLUB FOR THE LOCAL SCI COMMUNITY, AND 3) EXTEND ROWING PERFORMANCE AND EXERCISE INTENSITY BY TRANSLATING LABORATORY-BASED NEURAL STIMULATION TECHNIQUES TO ON-WATER SCULLING (E-SCULLING)</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4C</FormAndLineReferenceDesc>
        <ExplanationTxt>DR. PERI DAVITKOV, MD-NCI "FORTE (FIVE- OR TEN-YEAR COLONOSCOPY FOR 1-2 NON-ADVANCED ADENOMATOUS POLYPS)" THIS STUDY WILL HELP TO DETERMINE IF CERTAIN PEOPLE CAN WAIT FOR A FOLLOW- UP COLONOSCOPY AFTER A ROUTINE SCREENING COLONOSCOPY. IT IS A RANDOMIZED CLINICAL TRIAL FOR PEOPLE WHO HAVE ONE OR TWO SMALL, NONCANCEROUS POLYPS (ADENOMAS) REMOVED DURING A ROUTINE SCREENING COLONOSCOPY. SUCH PEOPLE USUALLY GET REPEAT COLONOSCOPIES 5 YEARS AND 10 YEARS LATER (THE CURRENT STANDARD OF CARE FOR PEOPLE WHO HAVE HAD ONE OR TWO BENIGN POLYPS REMOVED). FORTE WILL HELP DETERMINE IF THESE PEOPLE CAN WAIT 10 YEARS BEFORE A FOLLOW-UP TEST. A TOTAL OF 9,500 PEOPLE, AT ALL SITES, WHO HAVE HAD ONE OR TWO BENIGN (NONCANCEROUS) POLYPS REMOVED DURING A ROUTINE SCREENING COLONOSCOPY WILL BE ASSIGNED BY CHANCE TO ONE OF TWO STUDY GROUPS. IN ONE GROUP, PARTICIPANTS WILL HAVE REPEAT COLONOSCOPIES AT BOTH 5 AND 10 YEARS. IN THE OTHER GROUP, PARTICIPANTS WILL HAVE THEIR NEXT COLONOSCOPY EXAM AT 10 YEARS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4D</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER RESEARCH AND SERVICE ACTIVITIES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS AND IS REVIEWED, DISCUSSED, AND APPROVED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION IS REQUIRED BY THE U.S. DEPARTMENT OF VETERANS AFFAIRS TO MONITOR ITS CONFLICT OF INTEREST POLICY THROUGH ANNUAL CONFLICT OF INTEREST AND ETHICS CERTIFICATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS ONLY ONE COMPENSATED OFFICER, THE EXECUTIVE DIRECTOR. AN ANNUAL REVIEW OF ALL COMPENSATION FOR EMPLOYEES IS PERFORMED BY THE BOARD OF DIRECTORS. THE AMOUNT OF THE EXECUTIVE DIRECTOR'S SALARY THUS CALCULATED IS INCLUDED IN THE BUDGET WHICH IS APPROVED BY THE BOARD OF DIRECTORS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE FOR INSPECTION UPON WRITTEN REQUEST. THE ORGANIZATION DOES NOT GENERALLY MAKE ITS ORGANIZING DOCUMENTS OR CONFLICT OF INTEREST POLICY AVAILABLE TO THE GENERAL PUBLIC.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>